Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

596 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Choroidal metastasis as a presenting feature of breast carcinoma].
Pugnet G, Arista S, Martin-Blondel G, Roche H, Arlet-Suau E, Astudillo L. Pugnet G, et al. Among authors: roche h. Rev Med Interne. 2007 Nov;28(11):790-2. doi: 10.1016/j.revmed.2007.05.016. Epub 2007 Jun 8. Rev Med Interne. 2007. PMID: 17602802 French.
An unusual case of sarcoma of the breast.
Astudillo L, Lacroix-Triki M, Game X, Asnasios A, Leguevaque P, Roché H. Astudillo L, et al. Among authors: roche h. Breast J. 2005 Jan-Feb;11(1):74-5. doi: 10.1111/j.1075-122X.2005.21409.x. Breast J. 2005. PMID: 15647085 No abstract available.
[Breast cancer diagnostic assessment].
Dalenc F, Pons E, Roche H. Dalenc F, et al. Among authors: roche h. Rev Prat. 2017 Nov 20;67(9):e453-e454. Rev Prat. 2017. PMID: 30717583 French. No abstract available.
[Breast tumours].
Dalenc F, Pons E, Roché H. Dalenc F, et al. Among authors: roche h. Rev Prat. 2017 Nov 20;67(9):e445-e454. Rev Prat. 2017. PMID: 30516922 French. No abstract available.
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy.
Roché H, Yelle L, Cognetti F, Mauriac L, Bunnell C, Sparano J, Kerbrat P, Delord JP, Vahdat L, Peck R, Lebwohl D, Ezzeddine R, Curé H. Roché H, et al. J Clin Oncol. 2007 Aug 10;25(23):3415-20. doi: 10.1200/JCO.2006.09.7535. Epub 2007 Jul 2. J Clin Oncol. 2007. PMID: 17606972 Clinical Trial.
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.
Roché H, Conte P, Perez EA, Sparano JA, Xu B, Jassem J, Peck R, Kelleher T, Hortobagyi GN. Roché H, et al. Breast Cancer Res Treat. 2011 Feb;125(3):755-65. doi: 10.1007/s10549-010-1251-y. Epub 2010 Dec 3. Breast Cancer Res Treat. 2011. PMID: 21128114 Clinical Trial.
A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P, Campone M, Roché H, Gouraud W, Charbonnel C, Ricolleau G, Magrangeas F, Minvielle S, Genève J, Martin AL, Bataille R, Campion L. Jézéquel P, et al. Among authors: roche h. Breast Cancer Res Treat. 2009 Aug;116(3):509-20. doi: 10.1007/s10549-008-0250-8. Epub 2008 Nov 20. Breast Cancer Res Treat. 2009. PMID: 19020972
596 results